Portal hypertension after prolonged use of trastuzumab emtansine: nodular regenerative hyperplasia with autoimmune features. Research, Society and Development, [S. l.], v. 10, n. 8, p. e10810817005, 2021. DOI: 10.33448/rsd-v10i8.17005. Disponível em: https://rsdjournal.org/rsd/article/view/17005. Acesso em: 5 dec. 2025.